Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-08

Clinical Trial Update: Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prophylactic fluconazole to prevent invasive fungal infection in preterm and very low birth weight neonates; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)

Snippet

Sponsor: Services Institute of Medical Sciences, Pakistan | Conditions: Invasive Candidiases | Phase 3 | Status: COMPLETED